Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221.5 USD | -0.56% | +1.83% | -14.40% |
05-09 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
05-08 | Redburn Atlantic Adjusts Price Target on Biogen to $235 From $275, Keeps Neutral Rating | MT |
ETFs positioned on Biogen Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.30% | 0 M€ | -2.17% | - | |
3.92% | 0 M€ | 0.00% | - | |
3.75% | 0 M€ | 0.00% | - | |
2.39% | 0 M€ | +6.29% | ||
2.28% | 4 M€ | +20.15% | ||
1.91% | 6 M€ | +16.84% | - | |
1.78% | 0 M€ | +8.40% | - | |
1.69% | 0 M€ | +9.27% | ||
1.60% | 0 M€ | +4.88% | ||
1.33% | 0 M€ | +2.39% | ||
1.30% | 9 M€ | -4.31% | - | |
1.00% | 0 M€ | -4.02% | ||
0.99% | 0 M€ | +7.69% | - | |
0.97% | 13 M€ | -.--% | - | |
0.97% | 1 M€ | +11.94% | - | |
0.97% | 3 M€ | +7.32% | - | |
0.94% | 204 M€ | +10.54% | ||
0.65% | 2 M€ | -25.75% | ||
0.64% | 8 M€ | +5.48% | - | |
0.48% | 4,592 M€ | +11.18% | ||
0.44% | 1 M€ | +16.32% | ||
0.43% | 26 M€ | +16.85% | - | |
0.38% | 2 M€ | +20.44% | ||
0.38% | 0 M€ | 0.00% | - | |
0.37% | 5 M€ | -72.95% | - | |
0.37% | 9 M€ | -.--% | - | |
0.36% | 0 M€ | 0.00% | - | |
0.29% | 92 M€ | +0.06% | - | |
0.29% | 3,859 M€ | +18.82% | ||
0.29% | 469 M€ | -2.05% | ||
0.21% | 0 M€ | +5.63% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.40% | 32.25B | |
-2.61% | 89.08B | |
+3.55% | 40.9B | |
+55.89% | 25.14B | |
-15.96% | 15.39B | |
-15.50% | 11.91B | |
-41.29% | 11.89B | |
-11.75% | 11.64B | |
+7.87% | 9.03B | |
-3.16% | 8.62B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.